CVS HEALTH Corp·4

May 15, 5:19 PM ET

Balser Jeffrey R. 4

4 · CVS HEALTH Corp · Filed May 15, 2026

Research Summary

AI-generated summary of this filing

Updated

CVS Director Jeffrey Balser Receives 2,058-Share Award

What Happened Jeffrey R. Balser, a director of CVS Health Corp (CVS), was issued 2,058 shares on 2026-05-14 as an award (transaction code A). The shares were valued at $97.15 each, for a total reported value of $199,935. This was an award of common stock (not an open-market purchase or sale) issued as compensation.

Key Details

  • Transaction date: 2026-05-14; Filing date: 2026-05-15 (appears timely).
  • Price per share: $97.15; Shares issued: 2,058; Total value: $199,935.
  • Transaction type/code: A — grant/award of stock.
  • Footnote: Shares consist of common stock issued in payment of a semi-annual retainer at market price under the 2017 Incentive Compensation Plan.
  • Shares owned after transaction: not included in the provided filing excerpt.

Context Director awards like this are routine compensation for board service and do not by themselves signal a buy/sell decision. Compared with purchases or sales, awards mainly reflect pay practices rather than an insider betting on the stock. This transaction involved no option exercise, sale, 10% owner action, or 10b5-1 plan disclosure.

Insider Transaction Report

Form 4
Period: 2026-05-14
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-14$97.15/sh+2,058$199,93515,717 total
Footnotes (1)
  • [F1]Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
Signature
/s/ Jeffrey R. Balser|2026-05-15

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT